Synthetic Biology: Global Markets

Description

List of Tables

The global market for synthetic biology products was valued at $15.4 billion in 2023. The market is projected to grow from $19.3 billion in 2024 to $61.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 26.1% from 2024 through 2029.

The global synthetic biology market for enabled products is projected to grow from $10.1 billion in 2024 to $34.8 billion by the end of 2029, at a CAGR of 28.0% from 2024 through 2029.

The global synthetic biology market for enabling products is projected to grow from $6.8 billion in 2024 to $21.0 billion by the end of 2029, at a CAGR of 25.1% from 2024 through 2029.

Report Scope:

The study scope includes core synthetic biology products (e.g., oligonucleotides, synthetic genes, BioBrick parts, delivery plasmids, chassis organisms, synthetic cells, cell-based and cell-free production systems), enabling technologies (e.g., DNA sequencing, DNA synthesis, gene editing, bioinformatics, specialty media) and enabled technologies (e.g., healthcare, industrial chemicals, consumer products, food and beverage, agriculture) that are already commercialized or are forecast to be commercialized through 2029.

Key synthetic biology technologies and products are analyzed to determine present and future market status, as well as forecasted growth from 2024 through 2029. An in-depth discussion of strategic alliances, industry structures, competitive dynamics, patents, and market-driving forces is also provided.

BCC Research examines the synthetic biology industry by market segment, including DNA sequencing, DNA synthesis, gene editing, synthetic biology foundries, and software. The market is also analyzed by end users, including agriculture, consumer products, cosmetics and skin care, food and beverage, healthcare, and industrial chemicals.

By geographical region, the market is divided into four regions: North America, Europe, Asia-Pacific, and Rest of the World (RoW). For market estimates, data has been provided for 2023 as the base year, with forecasts for 2024 through 2029.

Report Includes:

50 data tables and 45 additional tables

An analysis of the global markets for synthetic biology products and technologies
Analyses of global market trends, with market revenue data from 2021 to 2023, estimates for 2024, and projected CAGRs through 2029
Estimates of the current market size and revenue prospects, along with market share analysis by product type, end-user industry and region
Facts and figures pertaining to the market drivers and challenges, innovations, technologies, industry regulations, and the influence of macroeconomic factors

Identification of core synthetic biology products, key enabling technologies, commercial opportunities for product development, and competitive strategies

Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, the ESG practices of leading companies and their ESG scores
An analysis of patents granted for synthetic biology technologies, liquid biopsy and sequencing, and gene editing
Analysis of the industry structure, including company market shares, strategic alliances, M&A activity and venture funding outlook
Profiles of the market leaders, including Ginkgo Bioworks, Amyris, Twist Bioscience, Codexis Inc., and Thermo Fisher Scientific Inc.

Product Code: BIO066H

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Summary

Chapter 2 Market Overview

Overview
Value Chain Analysis
Regulatory Framework
Regulation of GEMs in the United States
Impacts of Synthetic Biology on Biodiversity Conservation
Direct Impacts
Indirect Impacts

Chapter 3 Market Dynamics

Overview
Market Drivers
Various Applications of Synthetic Biology in Diverse Fields
Increasing Funding for Research and Development
Declining Cost of DNA Sequencing
Continuous Innovations in the Synthetic Biology Field
Market Restraints
Biosafety, Biosecurity, and Ethical Issues
Market Opportunities
Increasing Demand for Fuel Alternatives
Use of Machine Learning in Synthetic Biology

Chapter 4 Emerging Trends and Patent Analysis

Emerging Trends
CRISPR-Cas Systems
Gene Drives
Expanded Genetic Code
Optogenetics
Synthetic Genomics
Cell-Free System
Microbiome Engineering
Patent Analysis
Select Patent Grants
Patent Review

Chapter 5 Market Segmentation Analysis

Segmentation Breakdown
Market Analysis, by Product Type
Enabled Products
Enabling Products
Biologic Components
Integrated Systems
Market Analysis, by End User
Enabled Product, by End User
Enabling Product, by End User
Biologic Components, by End User
Integrated Systems, by End User
Geographic Breakdown
Market Analysis, by Region
North America
Europe
Asia-Pacific
Rest of the World

Chapter 6 Competitive Intelligence

Company Share Analysis
Investment in Industry

Chapter 7 Sustainability in Synthetic Biology Market: ESG Perspective

Overview
ESG Trends in the Biotechnology Industry
ESG Risks and Challenges
ESG Perspective
Environmental Impact
Social Impact
Governance and Ethical Considerations

Chapter 8 Appendix

Methodology
Sources
Acronyms
Company Profiles
AGILENT TECHNOLOGIES INC.
AMYRIS
CODEXIS INC.
EUROFINS SCIENTIFIC
GENSCRIPT
GINKGO BIOWORKS
MERCK KGAA
THERMO FISHER SCIENTIFIC INC.
TWIST BIOSCIENCE
VIRIDOS

Product Code: BIO066H

List of Tables

Summary Table : Global Market for Synthetic Biology, by Product Type, Through 2029
Table 1 : Challenges and Opportunities Posed by Synthetic Biology
Table 2 : Applications of SynBio in Various Aspects
Table 3 : Cost of Sequencing a Single Human Genome, 2001-2022
Table 4 : Applications of ML/DL in SynBio
Table 5 : List of Selected Patents Filed for Synthetic Biology, 2020
Table 6 : List of Selected Patents Filed for Synthetic Biology, 2021
Table 7 : List of Selected Patents Filed for Synthetic Biology, 2022
Table 8 : List of Selected Patents Filed for Synthetic Biology, 2023
Table 9 : List of Selected Patents Filed for Synthetic Biology, 2024
Table 10 : Top IPCR Codes and Their Descriptions
Table 11 : Global Synthetic Biology Market, by Product Type, Through 2029
Table 12 : Biodiesel Fuel Performance Comparison, 2024
Table 13 : Artemisinin Drug Production Comparison, 2024
Table 14 : Global Synthetic Biology Market for Enabled Products, by Region, Through 2029
Table 15 : Global Synthetic Biology Market for Enabling Products, by Product Type, Through 2029
Table 16 : Global Synthetic Biology Market for Enabling Products, by Region, Through 2029
Table 17 : Global Synthetic Biology Market for Biologic Components, by Product Type, Through 2029
Table 18 : Global Synthetic Biology Market for Biologic Components, by Region, Through 2029
Table 19 : Global Synthetic Biology Market for Integrated Systems, by Product Type, Through 2029
Table 20 : Global Synthetic Biology Market for Integrated Systems, by Region, Through 2029
Table 21 : Global Synthetic Biology Market, by End User, Through 2029
Table 22 : Global Synthetic Biology Enabled Product Market, by End User, Through 2029
Table 23 : Global Synthetic Biology Healthcare Market, by Sector, Through 2029
Table 24 : Global Synthetic Biology Consumer Products Market, by Sector, Through 2029
Table 25 : Global Synthetic Biology Food and Beverage Market, by Sector, Through 2029
Table 26 : Factors for Synthetic Biology-Based Chemical Processes
Table 27 : Global Synthetic Biology Industrial Chemicals Market, by Sector, Through 2029
Table 28 : Global Synthetic Biology Agriculture Market, by Sector, Through 2029
Table 29 : Global Synthetic Biology Enabling Product Market, by End User, Through 2029
Table 30 : Global Synthetic Biology Biologic Component Market, by End User, Through 2029
Table 31 : Global Synthetic Biology Integrated Systems Market, by End User, Through 2029
Table 32 : Global Synthetic Biology Market, by Region, Through 2029
Table 33 : North American Funding Organizations
Table 34 : North American Synthetic Biology Market, by Country, Through 2029
Table 35 : North American Synthetic Biology Market, by Product Type, Through 2029
Table 36 : U.S. Synthetic Biology Market, by Product Type, Through 2029
Table 37 : Canadian Synthetic Biology Market, by Product Type, Through 2029
Table 38 : Mexican Synthetic Biology Market, by Product Type, Through 2029
Table 39 : European Synthetic Biology Market, by Country, Through 2029
Table 40 : European Synthetic Biology Market, by Product Type, Through 2029
Table 41 : German Synthetic Biology Market, by Product Type, Through 2029
Table 42 : U.K. Synthetic Biology Market, by Product Type, Through 2029
Table 43 : French Synthetic Biology Market, by Product Type, Through 2029
Table 44 : Spanish Synthetic Biology Market, by Product Type, Through 2029
Table 45 : Italian Synthetic Biology Market, by Product Type, Through 2029
Table 46 : Rest of the European Synthetic Biology Market, by Product Type, Through 2029
Table 47 : Asia-Pacific Synthetic Biology Market, by Country, Through 2029
Table 48 : Asia-Pacific Synthetic Biology Market, by Product Type, Through 2029
Table 49 : Chinese Synthetic Biology Market, by Product Type, Through 2029
Table 50 : Japanese Synthetic Biology Market, by Product Type, Through 2029
Table 51 : Indian Synthetic Biology Market, by Product Type, Through 2029
Table 52 : South Korean Synthetic Biology Market, by Product Type, Through 2029
Table 53 : Rest of Asia-Pacific Synthetic Biology Market, by Product Type, Through 2029
Table 54 : Rest of the World Synthetic Biology Market, by Product Type, Through 2029
Table 55 : Selected Major Companies in Synthetic Biology, by Application, 2024
Table 56 : Report Information Sources
Table 57 : Glossary of Terms Used in the Global Synthetic Biology Market
Table 58 : Agilent Technologies Inc.: Company Snapshot
Table 59 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 60 : Agilent Technologies Inc.: Product Portfolio
Table 61 : Agilent Technologies Inc.: News/Key Developments, 2023
Table 62 : Amyris: Company Snapshot
Table 63 : Amyris: Product Portfolio
Table 64 : Amyris: News/Key Developments, 2021-2023
Table 65 : Codexis Inc.: Company Snapshot
Table 66 : Codexis Inc.: Financial Performance, FY 2022 and 2023
Table 67 : Codexis Inc.: Product Portfolio
Table 68 : Codexis Inc.: News/Key Developments, 2022
Table 69 : Eurofins Scientific: Company Snapshot
Table 70 : Eurofins Scientific: Financial Performance, FY 2022 and 2023
Table 71 : Eurofins Scientific: Product Portfolio
Table 72 : Eurofins Scientific: News/Key Developments, 2021-2023
Table 73 : GenScript: Company Snapshot
Table 74 : GenScript: Financial Performance, FY 2022 and 2023
Table 75 : GenScript: Product Portfolio
Table 76 : GenScript: News/Key Developments, 2021-2024
Table 77 : Ginkgo Bioworks: Company Snapshot
Table 78 : Ginkgo Bioworks: Financial Performance, FY 2022 and 2023
Table 79 : Ginkgo Bioworks: Product Portfolio
Table 80 : Ginkgo Bioworks: News/Key Developments, 2022-2024
Table 81 : Merck KGaA: Company Snapshot
Table 82 : Merck KGaA: Financial Performance, FY 2022 and 2023
Table 83 : Merck KGaA: Product Portfolio
Table 84 : Merck KGaA: News/Key Developments, 2022-2024
Table 85 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 86 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 87 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 88 : Thermo Fisher Scientific Inc.: News/Key Developments, 2022-2024
Table 89 : Twist Bioscience: Company Snapshot
Table 90 : Twist Bioscience: Financial Performance, FY 2022 and 2023
Table 91 : Twist Bioscience: Product Portfolio
Table 92 : Viridos: Company Snapshot
Table 93 : Viridos: Product Portfolio
Table 94 : Viridos: News/Key Developments, 2022-2023

List of Figures

Summary Figure : Global Market for Synthetic Biology, by Product Type, 2021-2029
Figure 1 : Value Chain Analysis: Synthetic Biology Market
Figure 2 : Synthetic Biology: Value-Added Chain
Figure 3 : Chart Outlining U.S. Regulatory Agencies that Regulate Specific GEMs
Figure 4 : Market Dynamics of Synthetic Biology Industry
Figure 5 : Funding in Synthetic Biology Sector, 2009-2020
Figure 6 : Global Biofuel Demand, Trends and Projections, 2016-2028
Figure 7 : Patents Documented, by Legal Status, 2020-2024
Figure 8 : Top IPCR Classification Codes, 2020-2024
Figure 9 : Global Synthetic Biology Market Share, by Product Type, 2023
Figure 10 : Global Synthetic Biology Market Share for Enabled Products, by Region, 2023
Figure 11 : Global Synthetic Biology Market Share for Enabling Products, by Product Type, 2023
Figure 12 : Global Synthetic Biology Market Share for Enabling Products, by Region, 2023
Figure 13 : Global Synthetic Biology Market Share for Biologic Components, by Product Type, 2023
Figure 14 : Global Synthetic Biology Market Share for Biologic Components, by Region, 2023
Figure 15 : Global Synthetic Biology Market Share for Integrated Systems, by Product Type, 2023
Figure 16 : Global Synthetic Biology Market Share for Integrated Systems, by Region, 2023
Figure 17 : Global Synthetic Biology Market Share, by End User, 2023
Figure 18 : Global Synthetic Biology Enabled Product Market Share, by End User, 2023
Figure 19 : Global Synthetic Biology Healthcare Market Share, by Sector, 2023
Figure 20 : Global Synthetic Biology Consumer Products Market Share, by Sector, 2023
Figure 21 : Global Synthetic Biology Food and Beverage Market Share, by Sector, 2023
Figure 22 : Global Synthetic Biology Industrial Chemicals Market Share, by Sector, 2023
Figure 23 : Global Synthetic Biology Agriculture Market Share, by Sector, 2023
Figure 24 : Global Synthetic Biology Enabling Product Market Share, by End User, 2023
Figure 25 : Global Synthetic Biology Biologic Component Market Share, by End User, 2023
Figure 26 : Global Synthetic Biology Integrated Systems Market Share, by End User, 2023
Figure 27 : Global Synthetic Biology Market Share, by Region, 2023
Figure 28 : North American Synthetic Biology Market Share, by Country, 2023
Figure 29 : European Synthetic Biology Market Share, by Country, 2023
Figure 30 : Asia-Pacific Synthetic Biology Market Share, by Country, 2023
Figure 31 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
Figure 32 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023
Figure 33 : Codexis Inc.: Revenue Share, by Business Unit, FY 2023
Figure 34 : Codexis Inc.: Revenue Share, by Country/Region, FY 2023
Figure 35 : Eurofins Scientific: Revenue Share, by Business Unit, FY 2023
Figure 36 : Eurofins Scientific: Revenue Share, by Country/Region, FY 2023
Figure 37 : GenScript: Revenue Share, by Business Unit, FY 2023
Figure 38 : GenScript: Revenue Share, by Country/Region, FY 2023
Figure 39 : Ginkgo Bioworks: Revenue Share, by Business Unit, FY 2023
Figure 40 : Merck KGaA: Revenue Share, by Business Unit, FY 2023
Figure 41 : Merck KGaA: Revenue Share, by Country/Region, FY 2023
Figure 42 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
Figure 43 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023
Figure 44 : Twist Bioscience: Revenue Share, by Business Unit, FY 2023
Figure 45 : Twist Bioscience: Revenue Share, by Country/Region, FY 2023

Synthetic Biology: Global Markets

Description

Table of Contents

List of Tables

Report Scope:

Report Includes:

Table of Contents

Chapter 1 Executive Summary

Chapter 2 Market Overview

Chapter 3 Market Dynamics

Chapter 4 Emerging Trends and Patent Analysis

Chapter 5 Market Segmentation Analysis

Chapter 6 Competitive Intelligence

Chapter 7 Sustainability in Synthetic Biology Market: ESG Perspective

Chapter 8 Appendix

List of Tables

List of Figures